Myelofibrosis - Winter Park FL (Clinical Trial # 10531)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials. 
| City: |
|
Winter Park |
| State: |
|
FL |
| Zip Code: |
|
32789 |
| Study summary: |
|
A Phase 1B, open label, dose finding study of an investigational medication administered orally to patients with primary myelofibrosis with low platelets. |
| Qualified participants must: |
|
• Be 18 years of age or older
•
Have a diagnosis of Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia-Myelofibrosis
•
Have baseline platelet counts ≥ 50K and <100K
|
| Participants may receive: |
|
All study related medication and care at no cost. There is no compensation for the study, although there may be reimbursement for travel expenses. |
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.